Company News
Shilpa Medicare Subsidiary Partners with Orion on Nivolumab Biosimilar
Shilpa Biologicals, a subsidiary of Shilpa Medicare, entered a co-development and supply agreement with Finland's Orion Corporation for an intravenous Nivolumab biosimilar.
The agreement covers develo
